 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/08/2026 |
$55.34 |
$55.92 |
$54.09 |
$55.74 |
1.09M | | 09/09/2026 |
$55.55 |
$57.14 |
$54.24 |
$54.65 |
1.41M | | 09/10/2026 |
$54.36 |
$55.41 |
$54.01 |
$55.39 |
1.37M | | 09/11/2026 |
$55.71 |
$56.26 |
$53.47 |
$53.89 |
1.37M | | 09/14/2026 |
$53.97 |
$54.20 |
$53.19 |
$54.00 |
1.36M |
 |
| TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. Co. is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. | |
 |

TG Therapeutics (TGTX) has the following price history information. Looking back at TGTX historical stock prices for the last five trading days, on September 08, 2026, TGTX opened at $55.34, traded as high as $55.92 and as low as $54.09, and closed at $55.74. Trading volume was a total of 1.09M shares. On September 09, 2026, TGTX opened at $55.55, traded as high as $57.14 and as low as $54.24, and closed at $54.65. Trading volume was a total of 1.41M shares. On September 10, 2026, TGTX opened at $54.36, traded as high as $55.41 and as low as $54.01, and closed at $55.39. Trading volume was a total of 1.37M shares. On September 11, 2026, TGTX opened at $55.71, traded as high as $56.26 and as low as $53.47, and closed at $53.89. Trading volume was a total of 1.37M shares. On September 14, 2026, TGTX opened at $53.97, traded as high as $54.20 and as low as $53.19, and closed at $54.00. Trading volume was a total of 1.36M shares.
TGTX Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into TG Therapeutics shares, starting with a $10,000 purchase of TGTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/16/2016 |
|
| End date: |
09/14/2026 |
|
| Start price/share: |
$7.29 |
|
| End price/share: |
$54.00 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
640.74% |
|
| Average Annual Total Return: |
22.17% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$74,070.58 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 09/08/2026 | $55.74 | | 09/09/2026 | $54.65 | | 09/10/2026 | $55.39 | | 09/11/2026 | $53.89 | | 09/14/2026 | $54.00 |
|
 |